Analysts/Institutional Investor Meet/Con. Call Updates

Akums Drugs and Pharmaceuticals has made available the audio recording of its Investors/Analysts Conference Call regarding the unaudited financial results for the quarter ended June 30, 2026. A transcript of the call will be shared with stock exchanges and uploaded on the company's website soon.